galantamine has been researched along with Respiratory Distress Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, F | 1 |
1 other study(ies) available for galantamine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway.
Topics: Arthritis, Rheumatoid; Cholinesterase Inhibitors; COVID-19; Galantamine; Humans; Neuroimmunomodulation; Pandemics; Respiratory Distress Syndrome; SARS-CoV-2; Vagus Nerve Stimulation | 2020 |